Preoperative Nomogram to Risk Stratify Patients for the Benefit of Trimodality Therapy in Esophageal Adenocarcinoma

被引：0
|
作者：
Lucas Goense
Peter S. N. van Rossum
Mian Xi
Dipen M. Maru
Brett W. Carter
Gert J. Meijer
Linus Ho
Richard van Hillegersberg
Wayne L. Hofstetter
Steven H. Lin
机构：
[1] The University of Texas MD Anderson Cancer Center,Department of Radiation Oncology
[2] University Medical Center Utrecht,Department of Radiation Oncology
[3] University Medical Center Utrecht,Department of Surgery
[4] Sun Yat-Sen University,Department of Radiation Oncology, Cancer Center
[5] State Key Laboratory of Oncology in South China,Department of Pathology
[6] Collaborative Innovation Centre for Cancer Medicine,Department of Diagnostic Radiology
[7] The University of Texas MD Anderson Cancer Center,Department of Gastrointestinal Medical Oncology
[8] The University of Texas MD Anderson Cancer Center,Department of Thoracic and Cardiovascular Surgery
[9] The University of Texas MD Anderson Cancer Center,undefined
[10] The University of Texas MD Anderson Cancer Center,undefined
来源：
Annals of Surgical Oncology | 2018年 / 25卷
关键词：
Trimodality Therapy; Bimodality Therapy; Signet Ring Cell Adenocarcinoma; Nomogram Score; Esophagectomy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1598 / 1607
页数：9
相关论文
共 50 条
  • [1] Preoperative Nomogram to Risk Stratify Patients for the Benefit of Trimodality Therapy in Esophageal Adenocarcinoma
    Goense, Lucas
    van Rossum, Peter S. N.
    Xi, Mian
    Maru, Dipen M.
    Carter, Brett W.
    Meijer, Gert J.
    Ho, Linus
    van Hillegersberg, Richard
    Hofstetter, Wayne L.
    Lin, Steven H.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (06) : 1598 - 1607
  • [2] Preoperative Nomogram for Early recurrence after Trimodality Therapy in Esophageal Adenocarcinoma.
    Goense, L.
    Van Rossum, P. S. N.
    Xi, M.
    Maru, D. P.
    Carter, B. W.
    Meijer, G. J.
    Ho, L.
    Van Hillegersberg, R.
    Hofstetter, W. L.
    Lin, S. H.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S52 - S53
  • [3] Nomogram validation for survival in patients with esophageal cancer receiving trimodality therapy.
    Goense, L.
    Merrell, K. W.
    Arnett, A. L.
    Hallemeier, C. L.
    Meijer, G. J.
    Ruurda, J. P.
    Hofstetter, W. L.
    Lin, S. H.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S84 - S84
  • [4] Preoperative Radiation Therapy in the Treatment of Resectable Esophageal Adenocarcinoma: Is There Really a Benefit?
    Allan, B.
    Pedroso, F.
    Prescott, A. T.
    Montero, A.
    Lally, B.
    Ardalan, B.
    Living-Stone, A. S.
    Koniaris, L. G.
    Franceschi, D.
    Solomon, N. L.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S135 - S135
  • [5] The Benefit of Chemotherapy in Esophageal Cancer Patients With Residual Disease After Trimodality Therapy
    Kim, Grace J.
    Koshy, Matthew
    Hanlon, Alexandra L.
    Horiba, M. Naomi
    Edelman, Martin J.
    Burrows, Whitney M.
    Battafarano, Richard J.
    Suntharalingam, Mohan
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2016, 39 (02): : 136 - 141
  • [6] Disparities in survival after trimodality therapy for esophageal adenocarcinoma
    Eng, O. S.
    Nelson, R. A.
    Konstantinidis, I.
    Chao, J.
    Erhunmwunsee, L.
    Raz, D. J.
    Kim, J. Y.
    DISEASES OF THE ESOPHAGUS, 2018, 31 (09)
  • [7] Validation of a Nomogram Predicting Survival After Trimodality Therapy for Esophageal Cancer
    Goense, Lucas
    Merrell, Kenneth W.
    Arnett, Andrea L.
    Hallemeier, Christopher L.
    Meijer, Gert J.
    Ruurda, Jelle P.
    Hofstetter, Wayne L.
    van Hillegersberg, Richard
    Lin, Steven H.
    ANNALS OF THORACIC SURGERY, 2018, 106 (05): : 1541 - 1547
  • [8] The Benefit of Adjuvant Chemotherapy in Esophageal Cancer Patients with Residual Disease following Trimodality Therapy
    Kim, G. J.
    Koshy, M.
    Horiba, M. N.
    Edelman, M. J.
    Doyle, L. A.
    Burrows, W. M.
    Battafarano, R. J.
    Krasna, M. J.
    Hanlon, A. L.
    Suntharalingam, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S72 - S73
  • [9] Survival Benefit of Trimodality Therapy in Lymph Node-Positive Patients with Esophageal Cancer
    Park, J.
    Kim, W.
    Kim, H.
    Gwak, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S321 - S321
  • [10] Survival in Patients With Esophageal Adenocarcinoma Undergoing Trimodality Therapy Is Independent of Regional Lymph Node Location
    Sepesi, Boris
    Schmidt, Henner E.
    Lada, Michal
    Correa, Arlene M.
    Walsh, Garrett L.
    Mehran, Reza J.
    Rice, David C.
    Roth, Jack A.
    Vaporciyan, Ara A.
    Ajani, Jaffer A.
    Watson, Thomas J.
    Swisher, Stephen G.
    Low, Donald E.
    Hofstetter, Wayne L.
    ANNALS OF THORACIC SURGERY, 2016, 101 (03): : 1075 - 1081
12345